TNFRSF9 and cancer: Costimulators include members of the tumor necrosis factor receptor family, such as OX40, 4-1BB, and CD40.144 Therapeutic activation of these costimulators may thus potentiate the activity of cancer vaccines, and experiments in murine cancer models support this notion.